{"corpus_id":636356,"paper_sha":"24e4811e512a048caf29aa43eb1184dd720a7e41","doi":"10.1056/NEJM199504203321603","arxiv_id":null,"pmid":7898523,"pmcid":null,"mag_id":2161676629,"dblp_id":null,"acl_id":null,"title":"Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy.","year":1995,"publication_date":"1995-04-20","venue":"New England Journal of Medicine","journal":{"name":"The New England journal of medicine","pages":"\n          1058-64\n        ","volume":"332 16"},"journal_issn":null,"journal_title":null,"publication_types":["JournalArticle"],"pubmed_pub_types":["Journal Article","Research Support, Non-U.S. Gov't","Research Support, U.S. Gov't, P.H.S."],"s2_fields_of_study":["Biology","Medicine"],"reference_count":24,"citation_count":930,"influential_citation_count":29,"is_open_access":true,"arxiv_categories":null,"arxiv_license":null,"arxiv_journal_ref":null,"mesh_headings":[{"d":"Adolescent","mj":false,"ui":"D000293"},{"d":"Adult","mj":false,"ui":"D000328"},{"d":"Biomarkers","mj":false,"ui":"D015415"},{"d":"Cardiomyopathy, Hypertrophic","mj":false,"qs":[{"q":"genetics","mj":true,"ui":"Q000235"}],"ui":"D002312"},{"d":"Genetic Linkage","mj":false,"ui":"D008040"},{"d":"Humans","mj":false,"ui":"D006801"},{"d":"Lod Score","mj":false,"ui":"D008126"},{"d":"Mutation","mj":true,"ui":"D009154"},{"d":"Myosins","mj":false,"qs":[{"q":"genetics","mj":false,"ui":"Q000235"}],"ui":"D009218"},{"d":"Phenotype","mj":false,"ui":"D010641"},{"d":"Polymorphism, Genetic","mj":false,"ui":"D011110"},{"d":"Tropomyosin","mj":false,"qs":[{"q":"genetics","mj":true,"ui":"Q000235"}],"ui":"D014335"},{"d":"Troponin","mj":false,"qs":[{"q":"genetics","mj":true,"ui":"Q000235"}],"ui":"D014336"},{"d":"Troponin T","mj":false,"ui":"D020107"}],"chemicals":[{"n":"Biomarkers","ui":"D015415","reg":"0"},{"n":"Tropomyosin","ui":"D014335","reg":"0"},{"n":"Troponin","ui":"D014336","reg":"0"},{"n":"Troponin T","ui":"D020107","reg":"0"},{"n":"Myosins","ui":"D009218","reg":"EC 3.6.4.1"}],"comments_corrections":null,"source_flags":5,"s2_open_access_pdf_url":"https://www.nejm.org/doi/pdf/10.1056/NEJM199504203321603?articleTools=true","s2_open_access_landing_url":"https://www.semanticscholar.org/paper/24e4811e512a048caf29aa43eb1184dd720a7e41","s2_open_access_license":null,"s2_open_access_status":"BRONZE","pmc_open_access_pdf_url":null,"pmc_open_access_landing_url":null,"pmc_open_access_license":null,"pmc_open_access_status":null,"unpaywall_open_access_pdf_url":null,"unpaywall_open_access_landing_url":null,"unpaywall_open_access_license":null,"unpaywall_open_access_status":null,"abstract":"BACKGROUND: Familial hypertrophic cardiomyopathy can be caused by mutations in the genes for beta cardiac myosin heavy chain, alpha-tropomyosin, or cardiac troponin T. It is not known how often the disease is caused by mutations in the tropomyosin and troponin genes, and the associated clinical phenotypes have not been carefully studied. METHODS: Linkage between polymorphisms of the alpha-tropomyosin gene or the cardiac troponin T gene and hypertrophic cardiomyopathy was assessed in 27 families. In addition, 100 probands were screened for mutations in the alpha-tropomyosin gene, and 26 were screened for mutations in the cardiac troponin T gene. Life expectancy, the incidence of sudden death, and the extent of left ventricular hypertrophy were compared in patients with different mutations. RESULTS: Genetic analyses identified only one alpha-tropomyosin mutation, identical to one previously described. Five novel mutations in cardiac troponin were identified, as well as a further example of a previously described mutation. The clinical phenotype of four troponin T mutations in seven unrelated families was similar and was characterized by a poor prognosis (life expectancy, approximately 35 years) and a high incidence of sudden death. The mean (+/- SD) maximal thickness of the left ventricular wall in subjects with cardiac troponin T mutations (16.7 +/- 5.5 mm) was significantly less than that in subjects with beta cardiac myosin heavy-chain mutations (23.7 +/- 7.7 mm, P < 0.001). CONCLUSIONS: Mutations in alpha-tropomyosin are a rare cause of familial hypertrophic cardiomyopathy, accounting for approximately 3 percent of cases. Mutations in cardiac troponin T account for approximately 15 percent of cases of familial hypertrophic cardiomyopathy in this referral-center population. These mutations are characterized by relatively mild and sometimes subclinical hypertrophy but a high incidence of sudden death. Genetic testing may therefore be especially important in this group.","claims":[{"public_id":"cl_406d2f6d15c2b2811395e180e5ee1c00","status":"active","text":"Alpha-tropomyosin mutations are a rare cause of familial hypertrophic cardiomyopathy, accounting for approximately 3% of cases in this referral-center population.","confidence":0.96,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_406d2f6d15c2b2811395e180e5ee1c00"},{"public_id":"cl_f5b21cc02eb379255545418862163fd9","status":"active","text":"Cardiac troponin T mutations account for approximately 15% of familial hypertrophic cardiomyopathy cases in this referral-center population.","confidence":0.97,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_f5b21cc02eb379255545418862163fd9"},{"public_id":"cl_0c9d48ecc9a43aec50ff8127dbe5f138","status":"active","text":"Cardiac troponin T mutations are associated with relatively mild and sometimes subclinical hypertrophy but a high incidence of sudden death and poor prognosis, with estimated life expectancy of about 35 years.","confidence":0.95,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_0c9d48ecc9a43aec50ff8127dbe5f138"},{"public_id":"cl_6d801068b24c18b4c670b0b5c2c45f63","status":"active","text":"Five novel cardiac troponin T mutations and one previously described alpha-tropomyosin mutation were identified by genetic analysis.","confidence":0.94,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_6d801068b24c18b4c670b0b5c2c45f63"},{"public_id":"cl_c566a9b1b6c59e7b4e313545abf6e89d","status":"active","text":"Maximal left ventricular wall thickness is significantly lower in subjects with cardiac troponin T mutations than in subjects with beta cardiac myosin heavy-chain mutations.","confidence":0.93,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_c566a9b1b6c59e7b4e313545abf6e89d"}],"concepts":[{"public_id":"co_03107bf899ef93b1487e430327c02458","status":"active","name":"sudden death","description":"Unexpected death occurring abruptly, used here as a clinical outcome associated with certain mutations.","types":["outcome"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_03107bf899ef93b1487e430327c02458"},{"public_id":"co_05e62eb7d5c03a664cba2379dc167458","status":"active","name":"poor prognosis","description":"An unfavorable expected clinical course or survival outlook.","types":["outcome"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_05e62eb7d5c03a664cba2379dc167458"},{"public_id":"co_07b4efb6fd0bbcf3719beb7e791beb8b","status":"active","name":"left ventricular hypertrophy","description":"Thickening of the left ventricular wall measured as maximal wall thickness in the study.","types":["clinical measurement","phenotype"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_07b4efb6fd0bbcf3719beb7e791beb8b"},{"public_id":"co_211ed6da8799bd7c91b024f690f1030a","status":"active","name":"beta cardiac myosin heavy-chain mutations","description":"Mutations in the gene encoding the beta cardiac myosin heavy chain, used here as a comparison group.","types":["mutation group","comparison group"],"aliases":["beta myosin heavy-chain mutations"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_211ed6da8799bd7c91b024f690f1030a"},{"public_id":"co_3b5ffde0fdafea4fd9419b3ad9c077ea","status":"active","name":"genetic analysis","description":"Molecular examination of genes to identify disease-associated mutations.","types":["method"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_3b5ffde0fdafea4fd9419b3ad9c077ea"},{"public_id":"co_4682d9affdf99f6fd3d886d9991af0d7","status":"active","name":"alpha-tropomyosin","description":"A muscle contractile protein encoded by a gene analyzed for mutations in familial hypertrophic cardiomyopathy.","types":["gene","protein"],"aliases":["alpha tropomyosin","TPM1"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_4682d9affdf99f6fd3d886d9991af0d7"},{"public_id":"co_5d3a1c718817cbdb6573ff7270fb1dce","status":"active","name":"familial hypertrophic cardiomyopathy","description":"An inherited form of hypertrophic cardiomyopathy seen in multiple family members.","types":["condition"],"aliases":["FHC"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_5d3a1c718817cbdb6573ff7270fb1dce"},{"public_id":"co_bcd14da651c110cc03a7b74757006cdc","status":"active","name":"referral-center population","description":"The patient population drawn from a clinical referral center and used for estimating mutation frequencies.","types":["study population"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_bcd14da651c110cc03a7b74757006cdc"},{"public_id":"co_c5deadb8d27f7b225801ad8818c44478","status":"active","name":"cardiac troponin T","description":"A cardiac contractile protein encoded by a gene screened for mutations in familial hypertrophic cardiomyopathy.","types":["gene","protein"],"aliases":["cTnT"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_c5deadb8d27f7b225801ad8818c44478"},{"public_id":"co_f4af6787646206265add7bcda3925300","status":"active","name":"subclinical hypertrophy","description":"Left ventricular thickening that may be present without obvious clinical symptoms.","types":["clinical feature"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_f4af6787646206265add7bcda3925300"}],"external_ids":{"DOI":"10.1056/NEJM199504203321603","ArXiv":null,"PubMed":7898523,"PubMedCentral":null,"MAG":2161676629,"DBLP":null,"ACL":null},"open_access":{"is_open_access":true,"pdf_url":"https://www.nejm.org/doi/pdf/10.1056/NEJM199504203321603?articleTools=true","landing_url":"https://www.semanticscholar.org/paper/24e4811e512a048caf29aa43eb1184dd720a7e41","source":"semantic_scholar","pdf_url_source":"semantic_scholar_open_access_pdf","license":null,"status":"BRONZE","reason":null},"reference_availability":{"status":"available","references_indexed":true,"full_text_available":false,"full_text_source":null,"count_basis":"semantic_scholar_metadata","extraction_status":"not_applicable","reason":null},"source":{"provider":"episteme2","base_corpus":"semantic_scholar_dump","freshness_mode":"unknown","basis":["semantic_scholar_metadata","postgres_metadata"],"limits":["paper metadata is based on indexed upstream scholarly datasets","claims and concepts are available only for extracted papers","absence of claims or concepts means no extracted graph data is available in this response"],"status":"available","degraded":false,"degraded_reasons":[],"diagnostics":{"status":"available","degraded":false,"degraded_reasons":[],"metadata_status":"available","graph_status":"available","abstract_status":"available"},"source_flags":5},"paper_id":631181,"paper_uid":"9af91ce1-4d5f-4de4-bd05-37745c4b8341","canonical_identity":{"paper_id":631181,"paper_uid":"9af91ce1-4d5f-4de4-bd05-37745c4b8341","identity_status":"available","lookup_basis":"semantic_scholar_external_id","compatibility_path":"corpus_id"},"url":"https://sah.borca.ai/papers/636356"}